Arch Therapeutics Inc (ARTH)

[BonelessCat]

That was the amended prospectus to include the spectacular results of the then just reported trial results. The updates to the prospectus have been regularly filed for every event, and in particular all the approved patent applications.

ARTH currently has sufficient funds to complete the CE process and start US trials as well as any further trials that might be requested from the EU authorities.